MedTrace Logo

Performance and FMRI BOLD Signal Changes in Impulsive Patients

NCT06491160 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-01-03

No results posted yet for this study

Summary

This study is a preceding study conducted to validate the methodology for assessing impulsivity by tasks and task-based fMRI measurements in patients with Attention Deficit Hyperactivity Disorder (ADHD) or Borderline Personality Disorder (BPD).

Conditions

  • Attention Deficit Hyperactivity Disorder
  • Borderline Personality Disorder

Sponsors & Collaborators

  • Charité Research Organisation GmbH

    collaborator OTHER

  • Boehringer Ingelheim

    collaborator INDUSTRY

  • Simone Grimm

    lead OTHER

Principal Investigators

  • Christian Keicher, Dr. med. · Charité Research Organisation, Berlin, Germany

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-06
Primary Completion
2024-10-30
Completion
2024-10-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06491160 on ClinicalTrials.gov